These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8795338)

  • 1. Lambert-Eaton (myasthenic) syndrome: pre-anaesthetic treatment with intravenous immunoglobulins.
    Biarnés A; Rochera MI
    Anaesthesia; 1996 Aug; 51(8):797. PubMed ID: 8795338
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy.
    Bird SJ
    Neurology; 1992 Jul; 42(7):1422-3. PubMed ID: 1620360
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
    Takano H; Tanaka M; Koike R; Nagai H; Arakawa M; Tsuji S
    Muscle Nerve; 1994 Sep; 17(9):1073-5. PubMed ID: 8065398
    [No Abstract]   [Full Text] [Related]  

  • 5. Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients.
    Tim RW; Massey JM; Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():823-6. PubMed ID: 9668336
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up of Lambert-Eaton syndrome treated with intravenous immunoglobulin.
    Muchnik S; Losavio AS; Vidal A; Cura L; Mazia C
    Muscle Nerve; 1997 Jun; 20(6):674-8. PubMed ID: 9149073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin.
    Counsell CE; McLeod M; Grant R
    Neurology; 1994 Jun; 44(6):1184-5. PubMed ID: 8208425
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolysis after high-dose intravenous Ig.
    Thomas MJ; Misbah SA; Chapel HM; Jones M; Elrington G; Newsom-Davis J
    Blood; 1993 Dec; 82(12):3789. PubMed ID: 8260715
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
    Peterlin BL; Flood W; Kothari MJ
    J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambert-Eaton myasthenic syndrome.
    Seneviratne U; de Silva R
    Postgrad Med J; 1999 Sep; 75(887):516-20. PubMed ID: 10616683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response to combined therapy with plasmapheresis and high doses of immunoglobulin in Lambert-Eaton syndrome].
    Díez-Tejedor E; Tejada J; Ramos MJ; Frank A; Cruz-Martínez A; Vivancos F; Barreiro P
    Neurologia; 1994 Feb; 9(2):76-7. PubMed ID: 8204254
    [No Abstract]   [Full Text] [Related]  

  • 12. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
    Nicolle MW
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1978-2005. PubMed ID: 27922503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambert-Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population.
    Abenroth DC; Smith AG; Greenlee JE; Austin SD; Clardy SL
    Muscle Nerve; 2017 Sep; 56(3):421-426. PubMed ID: 27997683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Lambert-Eaton syndrome with intravenous immunoglobulin.
    Rich MM; Teener JW; Bird SJ
    Muscle Nerve; 1997 May; 20(5):614-5. PubMed ID: 9140371
    [No Abstract]   [Full Text] [Related]  

  • 18. Myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Sanders DB; Guptill JT
    Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1413-25. PubMed ID: 25299290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma treatment in diseases of the neuromuscular junction.
    Cornelio F; Antozzi C; Confalonieri P; Baggi F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():803-10. PubMed ID: 9668333
    [No Abstract]   [Full Text] [Related]  

  • 20. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.